Claim Missing Document
Check
Articles

Found 2 Documents
Search

Adjunctive Micronutrient Therapy in Sepsis: Associations with Inflammation and Organ Dysfunction Prima , Agus; Lubis , Bastian
Journal of Society Medicine Vol. 5 No. 1 (2026): January
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v5i1.256

Abstract

Introduction: Despite advances in supportive care, sepsis remains a major cause of morbidity and mortality among critically ill patients. Adjunctive therapies targeting inflammation and endothelial dysfunction, such as thiamine and ascorbic acid, have gained increasing attention in recent years. Matrix metalloproteinase-9 (MMP-9) and its inhibitor TIMP-1 are key biomarkers involved in inflammatory dysregulation and organ dysfunction in sepsis. Methods: This retrospective cohort study was conducted over 12 months at Haji Adam Malik General Hospital. A total of 147 adult patients with sepsis were initially enrolled and categorized into four groups: normal saline (control), thiamine, ascorbic acid, and thiamine–ascorbic acid combination therapy. Propensity score matching was applied to achieve comparable baseline characteristics, resulting in 25 patients in each group. Serum MMP-9 and TIMP-1 levels were measured at the Integrated Laboratory, Faculty of Medicine, Universitas Sumatera Utara. The clinical outcomes included incidence rates, MMP-9/TIMP-1 ratios, and Sequential Organ Failure Assessment (SOFA) scores. Results: Combination therapy did not significantly reduce the incidence rate (OR 1.19; 95% CI 0.37–3.80) or MMP-9/TIMP-1 ratio (OR 0.34; 95% CI 0.09–1.30) compared to the control. In contrast, a single administration of ascorbic acid and thiamine significantly reduced the incidence rates and improved the MMP-9/TIMP-1 balance. Combination therapy was not associated with improved SOFA scores (OR 2.66; 95% CI 0.85–8.36). Conclusion: Combined thiamine and ascorbic acid therapies did not confer any superior clinical or biomarker benefits. Single-agent thiamine or ascorbic acid therapy demonstrated favorable effects on the incidence rate, MMP-9/TIMP-1 ratio, and organ dysfunction in patients with sepsis.
Anesthetic Management of Cavernous Sinus Meningioma with Pre-existing Cranial Nerve Deficits: A Case Report Rahmadhona, Sri; Lubis , Bastian
Journal of Society Medicine Vol. 5 No. 1 (2026): January
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v5i1.257

Abstract

Cavernous sinus meningioma poses significant neuroanesthetic challenges due to its skull base location, close proximity to critical neurovascular structures, and frequent association with pre-existing cranial nerve dysfunction. Optimal perioperative anesthetic management is essential for preserving cerebral perfusion pressure, maintaining optimal intracranial dynamics, and preventing secondary brain injury during complex skull base surgery. We report the perioperative anesthetic management of a 52-year-old woman with a right cavernous sinus meningioma who presented with a five-month history of progressive headache and multiple cranial nerve deficits, including ptosis, facial hypoesthesia, and deviation of the mouth and tongue, without limb motor weakness. The patient had long-standing poorly controlled hypertension and was classified as American Society of Anesthesiologists physical status III. Preoperative assessment demonstrated stable cardiopulmonary function, anisocoria, and preserved consciousness. Magnetic resonance imaging revealed a right cavernous sinus tumor measuring 2.4 × 1.7 × 1.9 cm. The patient underwent elective craniotomy and tumor removal under general anesthesia with endotracheal intubation. A comprehensive neuroprotective anesthetic strategy was implemented, including head-up positioning, controlled ventilation to maintain normocapnia, strict hemodynamic control to preserve cerebral perfusion pressure, and goal-directed fluid and blood management. The surgical procedure lasted six hours with an estimated blood loss of 1600 mL, managed with crystalloid, colloid, and blood component therapy. Postoperatively, the patient was managed in the intensive care unit with mechanical ventilation, adequate analgesia and sedation, osmotherapy, anticonvulsant prophylaxis, and close neurological monitoring. Despite transient metabolic acidosis, the patient remained hemodynamically stable, with preserved oxygenation and neurological improvement.